Options for screening for colorectal cancer

Scandinavian Journal of Gastroenterology, Supplement

Volumn 38, Issue 237, 2003, Pages 13-16

  Atkin, Wendy ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Colonoscopy; Colorectal cancer prevention; Colorectal cancer screening; Occult blood tests; Sigmoidoscopy

Indexed keywords

APC; DNA MARKER; PROTEIN P53; DNA; TUMOR MARKER;

ADENOMA; ASCENDING COLON; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER SURGERY; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DESCENDING COLON; DIAGNOSTIC ACCURACY; DNA EXTRACTION; ENDOSCOPY; FECES ANALYSIS; GENE MUTATION; HUMAN; HYPOTHESIS; INTERMETHOD COMPARISON; ITALY; OCCULT BLOOD; ONCOGENE K RAS; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; SIGMOIDOSCOPY; TUMOR VOLUME; UNITED KINGDOM; UNITED STATES; CHEMISTRY; COLORECTAL TUMOR; FECES; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; REVIEW;

ADENOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SIGMOIDOSCOPY; TUMOR MARKERS, BIOLOGICAL;

EID: 0037613270     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.1080/00855910310001421     Document Type: Conference Paper

References (39)

1. Mandel J, Bond J, Church T, Snover D, Bradley M, Schuman L. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
2. Mandel J, Church T, Ederer F, Bond J. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
3. Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
4. Jorgensen O, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and 7 biennial screening rounds. Gut 2002;50:29-32.
5. Hardcastle J, Chamberlain J, Robinson M, Moss S, Amar S, Balfour T, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
6. Mandel J, Church T, Bond J, Ederer F, Giesser M, Mongin S, et al. The effect of fecal occult blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
7. Lang C, Ransohoff D. Fecal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy? JAMA 1994;271:1011-3.
8. Ahlquist D, Wieand H, Moertal C, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and Hemoquant. J Am Med Ass 1993;269:1262-7.
9. Saito H. Screening for colorectal-cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res 1996;87:1011-24.
10. Rozen P, Knaani J, Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer 2000;89:46-51.
11. Castiglione G, Zappa M, Grazzini G, Rubeca T, Turco P, Sani C, et al. Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests. J Med Screen 2000;7:35-7.
12. Steele R, Parker R, Patnick J, Warner J, Fraser C, Mowat N, et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen 2001;8:197-203.
13. Atkin W, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, et al. Single-blind, randomised trial of the efficacy and acceptability of oral Picolax vs self-administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening. Br Med J 2000;320:1504-9 discussion 1509.
14. Selby J, Friedman G, Jr CQ, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
15. Newcomb P, Norfleet R, Storer B, Surawicz S, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
16. Muller A, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-controlled study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
17. Gilbertsen V, Nelms J. The prevention of invasive cancer of the rectum. Cancer 1978;41:1137-9.
18. Atkin W, Edwards R, Wardle J, Northover J, Sutton S, Hart A, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-44.
19. Segnan N, Sciallero S, Bonelli L, Andreoni B, Crosta C, Cardelli A, et al. Multicentre randomised controlled trial of 'once only' flexible sigmoidoscopy screening in Italy score. Endoscopy 1999;31 Suppl 1:E9.
20. Prorok P, Andriole G, Bresalier R, Buys S, Chia D, Crawford E, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials 2000;21 Suppl 6:273S-309S.
21. US Preventive Services Task Force. Screening for colorectal cancer: recommendations and rationale. Ann Intern Med 2002;137:129-31.
22. Selby J, Friedman G. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser-Permanente multiphasic evaluation study. J Clin Epidemiol 1988;41:427-34.
23. Atkin W, Cuzick J, Northover J, Whynes D. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993;341:736-40.
24. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer; baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-300.
25. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, et al. Baseline findings of the Italian multicentre randomised controlled trial of 'once-only sigmoidoscopy'. J Natl Cancer Inst 2002. In press.
26. Kavanagh A, Giovannucci E, Fuchs C, Colditz G. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 1998;9:455-62.
27. Winawer S, Zauber A, O'Brien M, Ho M, Gottlieb L, Sternberg S. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
28. Winawer S, Zauber A. Colonoscopic polypectomy and the incidence of colorectal cancer. Gut 2001;48:753-6.
29. Anderson M, Pasha T, Leighton J. Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol 2000;95:3418-22.
30. Levin T, Palitz A. Flexible sigmoidoscopy; an important screening option for average-risk individuals. Gastrointest Endosc Clin N Am 2002;12:23-40.
31. Schoenfeld P, Cash B, Kita J, Piorkowski M, Cruess D, Ransohoff D. Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses. Gastrointest Endosc 1999;49:158-62.
32. Ahlquist D, Skoletsky J, Boynton K, Harrington J, Mahoney D, Pierceall W, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-27.
33. Rengucci C, Maiolo P, Saragoni L, Zoli W, Amadori D, Calistri D. Multiple detection of genetic alterations in tumors and stool. Clin Cancer Res 2001;7:590-3.
34. Dong S, Traverso G, Johnson C, Geng L, Favis R, Boynton K, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. JNCI 2001;93.
35. Traverso G, Shuber A, Olsson L, Levin B, Johnson C, Hamilton S. et al. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 2002;359:403-4.
36. Fenlon H. Virtual colonoscopy. Br J Surg 2002;89:1-3.
37. Callstrom M, Johnson C, Reed J, Ahlquist D, Corcoran K, Clin M, et al. CT colonography of the unprepped colon: an early feasibility study of 'virtual preparation'. Gastroenterology 2000;118 Suppl 2:A257.
38. Lauenstein T, Goehde S, Ruehm S, Holtmann G, Debatin J. MR colonography with barium-based fecal tagging: initial clinical experience. Radiology 2002;223:248-54.
39. Summers R, Johnson C, Pusunik L, Malley J, Youssef A, Reed J. Automated polyp detection at CT colonography: feasibility assessment in a human population. Radiology 2001;219:51-9.